The Effect of Transcranial Direct Current Stimulation on Fatigue Among Multiple Sclerosis Patients.Patients
1 other identifier
interventional
36
0 countries
N/A
Brief Summary
This work is aimed to assess the long term effect of TDCS in fatigue management among MS patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Dec 2022
Shorter than P25 for not_applicable multiple-sclerosis
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2022
CompletedFirst Posted
Study publicly available on registry
September 29, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedSeptember 29, 2022
September 1, 2022
5 months
May 18, 2022
September 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
fatigue assessment scale
it is a acale filed by the patient and it consists of scale from 1 to 10
at post sessions, 1 month and 2 month post sessions
visual analogue scale
it is a scale from 0 to 10 to assess major fatigue
at post sessions, 1 month and 2 month post sessions
Secondary Outcomes (1)
changes in cortical excitability parameters at post 10th session compared to baseline measurements of cortical excitability parameters
at post sessions, 1 month and 2 month post sessions
Study Arms (2)
experimental group
EXPERIMENTALParticipants in the experimental groups received ten -sessions a-tDCS (1.5mA, 20minutes) anodal stimulation of left DLPC over two weeks duration (five sessions per week).
sham group
SHAM COMPARATORThe sham group received ten sessions of sham stimulation for 20-minutes in each session.
Interventions
Eligibility Criteria
You may qualify if:
- Any adult patient will be fulfilling diagnostic criteria of Multiple sclerosis and could be providing consent for participation in the study, will be included in the study.
You may not qualify if:
- any patient showed this following condition will be excluded from the study;
- Any MS patient had any contraindication condition to use TMS or TCDS (such as epilepsy, head trauma, metallic procedure, cerebral insult)
- Any patient had infection or febrile condition.
- Any patient had other co morbid neurological or psychiatric disorders or systemic disease.
- Any patient refuses participation in study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
- Compston A, Coles A. Multiple sclerosis. Lancet.
- Tellez N et al. Fatigue in multiple sclerosis persists over time: a longitudinal study. J Neurol
- Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. Mult Scler
- Ghajarzadeh M, Jalilian R, Eskandari G, et al. Fatigue in multiple sclerosis: Relationship with disease duration, physical disability, disease pattern, age and sex. Acta Neurol Belg
- Chen MY, Wang EK, Jeng YJ. Adequate sleep among adolescents is positively associated with health status and health-related behaviors. BMC Public Health
- Genova HM, Rajagopalan V, Deluca J, et al. Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging. PLoS ONE.
- Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinson's disease
- Multi-session anodal transcranial direct current stimulation enhances lower extremity functional performance in healthy older adults
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Noha M Abo-Elfetoh, PHD
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Anodal, or sham with a ratio 1:1 were placed in serially numbered opaque closed envelopes. Each patient was given a serial number from a computer generated randomization table, and was placed in the appropriate group after opening the corresponding sealed envelope.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 18, 2022
First Posted
September 29, 2022
Study Start
December 1, 2022
Primary Completion
May 1, 2023
Study Completion
September 1, 2023
Last Updated
September 29, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL